Company news
Claritas Pharmaceuticals Inc. news in 2019
Claritas Pharmaceuticals Inc.'s news releases, calls and decks from 2019, newest first.
Kalytera Announces Intention to Seek Amendment of Secured Convertible Debentures Due December 2019
December 20, 2019
Kalytera Announces Extension of Maturity Date of Promissory Note
December 16, 2019
Kalytera Reports Third Quarter 2019 Financial Results
December 2, 2019
Published Studies Provide Further Support For Kalytera’s Program Evaluating CBD in GVHD
November 22, 2019
Kalytera Announces Closing of Final Tranche of Private Placement of Common Shares and Common Share Purchase Warrants and Amendments to Secured Convertible Debenture Units
October 30, 2019
Kalytera Provides Update on Private Placement of Common Shares and Common Share Purchase Warrants
October 21, 2019
Kalytera Terminates Plan to Acquire CBD Extraction Facility
October 17, 2019
Kalytera Announces Notice of Allowance of EU Patent for Prevention and Treatment of Graft Versus Host Disease
October 2, 2019
Kalytera Announces Closing of First Tranche of Private Placement of Common Shares and Common Share Purchase Warrants
September 16, 2019
Kalytera Announces Update to Private Placement
September 11, 2019
Kalytera Announces Interest Payment in Shares
September 9, 2019
Kalytera Reports Second Quarter 2019 Financial Results
August 29, 2019
Kalytera Announces Management-Led Private Placement of Up To $1.5 Million of Common Shares and Common Share Purchase Warrants
August 21, 2019
Kalytera to Conclude Phase 2 Clinical Study and Initiate Phase 3 Study
August 20, 2019
Kalytera Announces Results of Shareholder Meeting Votes
July 29, 2019
Kalytera Will Not Proceed with Vote on Potential Share Consolidation
July 26, 2019
Kalytera Announces Completion of Food Effect and QTc Study
July 16, 2019
Kalytera to Hold Annual and Special Meeting on July 29, 2019
July 5, 2019
Kalytera to Acquire CBD Extraction Business
June 27, 2019
Kalytera Provides Update on GVHD Program
June 25, 2019
Kalytera Announces Grant of Stock Options to Directors
June 21, 2019
Kalytera Announces Changes to Board of Directors
June 21, 2019
Kalytera Announces Additional Progress with Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain
June 18, 2019
Kalytera Reports First Quarter 2019 Financial Results
May 31, 2019
Kalytera Announces Submission of Patent Application to the U.S. Patent and Trademark Office
May 29, 2019
Kalytera Announces Data Further Elucidating CBD’s Mechanisms of Action in Prevention of GVHD
May 28, 2019
Kalytera Announces Engagement of Echelon Wealth Partners to Assist with Review of Potential Out-License Opportunities for Commercial Rights to GVHD Products
May 21, 2019
Kalytera Therapeutics, Inc. Announces Second Closing of Public Offering
May 14, 2019
Kalytera Reports 2018 Financial Results
May 1, 2019
Kalytera Therapeutics, Inc. Announces Closing of Public Offering
April 26, 2019
Kalytera Therapeutics Announces Filing of Short Form Prospectus
April 17, 2019
Kalytera Therapeutics Announces Short Form Prospectus Offering of Units
April 3, 2019
Kalytera Reports Data for First Cohort in Phase 2 Clinical Study Evaluating CBD in Prevention of Acute GVHD
March 22, 2019
Kalytera Announces Closing of Private Placement of Convertible Debenture Units
March 7, 2019
Kalytera Announces Initiation of Study KAL-07 – Food Effect Study
March 6, 2019
Kalytera Announces Private Placement of Convertible Debenture Units
March 5, 2019
Kalytera Announces Share Issuance for January Invoices under Payments Agreements with Salzman Group
February 26, 2019
Kalytera Reports Additional Positive Data for CBD in Prevention of Acute GVHD
February 5, 2019
KALY - Kali-Extracts, Inc. Announces Cannabis Extract COPD Primate Treatment Study Research Report Preview
February 1, 2019
Kalytera Announces Change to Scope of Services under Payments Agreements with Salzman Group and Next Share Issuance
January 31, 2019
Kalytera Announces Grant of Stock Options to Certain Directors and Employees
January 28, 2019
Kalytera Announces Closing of Private Placement of Common Shares and Common Share Purchase Warrants
January 22, 2019
Kalytera Announces Initiation of Research Coverage by Echelon Wealth Partners
January 15, 2019
Kalytera Announces Share Issuance and Extension to March 1 under Payments Agreements with Salzman Group
January 14, 2019
Kalytera Announces Private Placement of Common Shares and Common Share Purchase Warrants
January 11, 2019